SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-23-000894
Filing Date
2023-01-11
Accepted
2023-01-11 16:08:06
Documents
2
Period of Report
2023-01-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_167347123917594.html 3  
1 FORM 3 wf-form3_167347123917594.xml 3 2247
2 POWER OF ATTORNEY_NC ex-24.htm EX-24 3681
  Complete submission text file 0001628280-23-000894.txt   7399
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1415 RANCH ROAD 620 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address
Calloway Nathaniel (Reporting) CIK: 0001952771 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27446 | Film No.: 23523674